146 related articles for article (PubMed ID: 34290523)
1. Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer.
Gong MC; Chen WQ; Jin ZQ; Lyu J; Meng LH; Wu HY; Chen FH
Int J Gen Med; 2021; 14():3485-3496. PubMed ID: 34290523
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of xenotropic and polytropic retrovirus receptor 1 in papillary thyroid carcinoma.
Zou H; Xiang C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):90-96. PubMed ID: 34117845
[TBL] [Abstract][Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma.
Jiang MM; Zhao F; Lou TT
Int J Gen Med; 2021; 14():2329-2341. PubMed ID: 34113163
[TBL] [Abstract][Full Text] [Related]
5. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
6. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.
Meng J; Wei Y; Deng Q; Li L; Li X
Cancer Cell Int; 2022 Jan; 22(1):29. PubMed ID: 35033076
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between TOPA2A gene expression and the number of CD4
Lu X; Yu P; Tao H; Chen Y; Lu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jan; 38(1):24-31. PubMed ID: 35078572
[TBL] [Abstract][Full Text] [Related]
10. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
11. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
12. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
14. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
Gu Y; Feng C; Liu T; Zhang B; Yang L
PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
[TBL] [Abstract][Full Text] [Related]
15. EPAS1/HIF-2α Acts as an Unanticipated Tumor-Suppressive Role in Papillary Thyroid Carcinoma.
Zhang R; Zhao J; Zhao L
Int J Gen Med; 2023; 16():2165-2174. PubMed ID: 37284036
[TBL] [Abstract][Full Text] [Related]
16. Expression of ANGPTL2 and its impact on papillary thyroid cancer.
Yang L; Sun R; Wang Y; Fu Y; Zhang Y; Zheng Z; Ji Z; Zhao D
Cancer Cell Int; 2019; 19():204. PubMed ID: 31384179
[TBL] [Abstract][Full Text] [Related]
17. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer.
Li H; Liu F; Wang X; Li M; Li Z; Xie Y; Guo Y
Front Pharmacol; 2021; 12():748867. PubMed ID: 34721037
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.
Tavarelli M; Sarfati J; Chereau N; Tissier F; Golmard JL; Ghander C; Lussey-Lepoutre C; Trésallet C; Menegaux F; Leenhardt L; Buffet C
Thyroid; 2017 Jun; 27(6):778-786. PubMed ID: 28351220
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "SLC34A2" in Papillary Thyroid Carcinoma: An Immunohistochemical Study.
Hakim SA; Abd El Atti RM; Faheim RM; Abou Gabal HH
Anal Cell Pathol (Amst); 2021; 2021():3198555. PubMed ID: 34336552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
